Comparison of immune checkpoint inhibitors related to pulmonary adverse events: a retrospective analysis of clinical studies and network meta-analysis

Comparison of immune checkpoint inhibitors related to pulmonary adverse events: a retrospective analysis of clinical studies and network meta-analysis

Abstract Background Immune checkpoint inhibitors (ICIs) have transformed tumor treatment. However, the risk of pulmonary adverse events (PAEs) associated with ICI combination therapy is still unclear. We aimed to provide a PAE overview and risk ordering of ICIs used in tumor treatment. Methods We se...

Full description

Bibliographic Details
Main Authors: Baohui Hong, Bin Du, Rong Chen, Caiyun Zheng, Ruping Ni, Maobai Liu, Jing Yang
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Medicine
Subjects:
Tumor
Immune checkpoint inhibitors
Treatment-related adverse events
Pulmonary adverse events
Online Access:https://doi.org/10.1186/s12916-024-03285-3

Internet

https://doi.org/10.1186/s12916-024-03285-3

Similar Items